In trading today, Hls Therapeutics Inc opened at $4.65 and closed at $4.65. Intraday prices ranged from a low of $4.65 to a high of $4.65.

The price $verbed percentage_change percent from the previous day's close of $4.65.

During the day across North America, the TSX Composite closed -1.35% at 21714.54, the S&P 500 closed 0.32% at 5116.17, the Dow Jones Industrial Average closed 0.38% at 38386.09 and the Nasdaq Composite closed 0.35% at 15983.08.

Hls Therapeutics Inc traded under HLS on the Toronto Stock Exchange (TSX).

A total of 5,000 shares was traded during the last trading day, with total trades of 6, while having an average volume of 3,222 in the last five days.

Trading across the entire TSX saw 1,288 price advancers against 3,926 declines and 104 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $7.12 (July 17,2023) and low as $3.34 (November 27,2023). Moreover, the shares have decreased -16.96% in the last 12 months, while in 2024, they have boosted 17.72%.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $148.27 million on a float of 31,886 shares outstanding. Its annual EPS is $-0.85.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Currently, Hls Therapeutics Inc has an average recommendation of "Moderate Buy" based on 5.00 analysts according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..